Marc J. Ostro
10Patents
10h-index
18Co-inventors
65Inventor score
Filing activity: Mar 24, 1983 → Nov 3, 1994
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4522803A | Stable plurilamellar vesicles, their preparation and use | Emerging Cross-Sectional Technologies | 276 | Expired |
| US5169637A | Stable plurilamellar vesicles | Emerging Cross-Sectional Technologies | 146 | Expired |
| US5154930A | Pharmacological agent-lipid solution preparation | Emerging Cross-Sectional Technologies | 110 | Expired |
| US5030453A | Stable plurilamellar vesicles | Human Necessities | 102 | Expired |
| US5059591A | Drug preparations of reduced toxicity | Human Necessities | 100 | Expired |
| US4897384A | Drug preparations of reduced toxicity | Human Necessities | 61 | Expired |
| US4668638A | Liposome composition for lupus assay | Emerging Cross-Sectional Technologies | 26 | Expired |
| US4564599A | Liposome composition for lupus assay | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5925375A | Therapeutic use of multilamellar liposomal prostaglandin formulations | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5811118A | Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations | Emerging Cross-Sectional Technologies | 11 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.